FUJIFILM Diosynth Biotechnologies And Roosterbio Announce Collaboration To Enable GMP Manufacturing Of Cell And Exosome Therapies
October 25, 2022
October 25, 2022
COLLEGE STATION, Texas, Oct. 25 -- Fujifilm USA issued the following news on Oct. 24, 2022:
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced today a strategic collaboration with RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services. Through this collaboration, FUJIFILM Diosy . . .
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced today a strategic collaboration with RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services. Through this collaboration, FUJIFILM Diosy . . .